Reshma Kewalramani's Net Worth
Reshma Kewalramani's net worth is estimated to be at least $35,674,009.35 as of 12/23/2024. CoreStreet's estimation of Reshma Kewalramani's net worth is based on their sale of stock and current holding of stock.
Reshma Kewalramani is Insider at Vertex Pharmaceuticals Inc. They have executed at least 18 trades of stock as per SEC Form 4 filings. Their most recent trade was for 15,202 units of VRTX stock on 07/30/2024. Their biggest sale was on 07/22/2024 when they sold 15,202 units of Vertex Pharmaceuticals Inc stock for $7,555,394.00. They typically trade 2 times per year.
Total value of insider buys:
- $9,633,510.00
Total value of insider sells:
- $26,040,499.35
Most recent insider trade:
- July 30, 2024
Reshma Kewalramani's Insider Trading History
| Vertex Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
July 30, 2024 | Insider | 15,202 | $505.00 | Buy | $7,677,010.00 |
July 22, 2024 | CEO | 15,202 | $497.00 | Sell | $7,555,394.00 |
May 24, 2024 | CEO | 1,565 | $457.00 | Sell | $715,205.00 |
July 17, 2023 | CEO | 7,828 | $355.00 | Sell | $2,778,940.00 |
April 27, 2023 | CEO | 3,317 | $339.08 | Sell | $1,124,728.36 |
Jan. 25, 2023 | CEO | 10,000 | $315.05 | Sell | $3,150,500.00 |
Aug. 15, 2022 | CEO | 11,689 | $305.06 | Sell | $3,565,846.34 |
June 24, 2022 | CEO | 11,689 | $291.30 | Sell | $3,405,005.70 |
Aug. 19, 2021 | CEO | 10,000 | $195.65 | Buy | $1,956,500.00 |
Feb. 25, 2020 | CMO | 3,634 | $233.45 | Sell | $848,357.30 |
Feb. 18, 2020 | CMO | 1,183 | $243.51 | Sell | $288,072.33 |
Nov. 25, 2019 | CMO | 4,692 | $219.37 | Sell | $1,029,284.04 |
Nov. 8, 2019 | CMO | 509 | $199.00 | Sell | $101,291.00 |
Oct. 30, 2019 | CMO | 3,057 | $199.00 | Sell | $608,343.00 |
Oct. 22, 2019 | CMO | 638 | $189.00 | Sell | $120,582.00 |
May 15, 2019 | CMO | 241 | $165.41 | Sell | $39,863.81 |
Feb. 19, 2019 | CMO | 1,488 | $186.94 | Sell | $278,166.72 |
Oct. 8, 2018 | CMO | 2,305 | $186.95 | Sell | $430,919.75 |